カテゴリ： MarketLine, 企業調査, 香港

New World Development Company Limited：企業の戦略・SWOT・財務情報

◆英語タイトル：New World Development Company Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3751
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：46
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：香港
◆産業分野：建設・建築
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

New World Development Company Limited – Strategy, SWOT and Corporate Finance Report
Summary

New World Development Company Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

New World Development Company Limited (NWD) is a Hong Kong-based conglomerate operates a range of business including property development and investment, infrastructure, service, department stores, and hotels and serviced apartments. Moreover the NWD group has owns two publicly traded companies, NWS Holdings Limited and New World Department Store China Limited. Moreover, the group operates various businesses in China and it is one of the largest foreign direct investor in the country. MWD operates in Hong Kong, Macau, and Mainland China. It is headquartered in Central, Hong Kong.

Scope

- Detailed information on New World Development Company Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting New World Development Company Limited in the form of a SWOT analysis
- An in-depth view of the business model of New World Development Company Limited including a breakdown and examination of key business segments
- Intelligence on New World Development Company Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about New World Development Company Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of New World Development Company Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess New World Development Company Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on New World Development Company Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
New World Development Company Limited: Company Overview 9
New World Development Company Limited: Overview and Key Facts 9
New World Development Company Limited: Overview 9
New World Development Company Limited: Key Facts 9
New World Development Company Limited: Key Employees 10
New World Development Company Limited: Key Employee Biographies 11
New World Development Company Limited: Major Products and Services 17
New World Development Company Limited: Company History 18
New World Development Company Limited: Management Statement 21
New World Development Company Limited: Locations and Subsidiaries 23
New World Development Company Limited: Key Competitors 24
New World Development Company Limited: Company Analysis 25
New World Development Company Limited: Business Description 25
New World Development Company Limited: SWOT Analysis 27
New World Development Company Limited: SWOT Overview 27
New World Development Company Limited: Strengths 27
New World Development Company Limited: Weaknesses 28
New World Development Company Limited: Opportunities 28
New World Development Company Limited: Threats 29
New World Development Company Limited: Corporate Financial Deals Activity 30
New World Development Company Limited: Financial Deals Overview 30
New World Development Company Limited: Targets and Partners 32
New World Development Company Limited: Top Deals 2014 – 2018YTD* 33
New World Development Company Limited: Advisors 34
New World Development Company Limited: Top Financial Advisors 34
New World Development Company Limited: Mergers and Acquisitions 35
New World Development Company Limited: Corporate Venturing 36
New World Development Company Limited: Recent Developments 37
New World Development Company Limited: News and Events Summary 37
New World Development Company Limited: Business Expansion 39
New World Development Company Limited: Contracts 40
New World Development Company Limited: Corporate Governance 41
New World Development Company Limited: Financial Performance 41
New World Development Company Limited: Strategy and Operations 42
Appendix 44
Contact Us 44
Methodology 44
About MarketLine 45

List of Tables
Table 1: New World Development Company Limited: Key Facts
Table 2: New World Development Company Limited: Key Employees
Table 3: New World Development Company Limited: Locations and Subsidiaries
Table 4: New World Development Company Limited: Key Competitors
Table 5: New World Development Company Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 6: New World Development Company Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: New World Development Company Limited: Targets and Partners
Table 8: New World Development Company Limited: Top Deals 2014 - 2018YTD*
Table 9: New World Development Company Limited: Financial Advisor Ranking by Value (US$m)
Table 10: New World Development Company Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: New World Development Company Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 12: New World Development Company Limited: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 13: New World Development Company Limited: Corporate Venturing by Geography (2014 - YTD*2018)
Table 14: New World Development Company Limited: News and Events Summary
Table 15: New World Development Company Limited: Business Expansion
Table 16: New World Development Company Limited: Contracts
Table 17: New World Development Company Limited: Corporate Governance
Table 18: New World Development Company Limited: Financial Performance
Table 19: New World Development Company Limited: Strategy and Operations

List of Figures
Figure 1: New World Development Company Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: New World Development Company Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: New World Development Company Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: New World Development Company Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: New World Development Company Limited: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 6: New World Development Company Limited: Corporate Venturing by Geography (2014 - YTD*2018)

★海外企業調査レポート[New World Development Company Limited：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • International SOS Pte Ltd：企業の戦略的SWOT分析
    International SOS Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mistras Group Inc (MG)：企業の財務・戦略的SWOT分析
    Summary Mistras Group Inc (Mistras) is a provider of technology-enabled asset protection solutions that offers used to evaluate the structural integrity of critical energy, industrial and public infrastructure. The company provides products such as acoustic emission, ultrasonic, and vibration and Pd …
  • Galderma SA：医療機器：M&Aディール及び事業提携情報
    Summary Galderma SA (Galderma), a subsidiary of Nestle SA, is a pharmaceutical company that develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions s …
  • Summer Infant, Inc.：企業の戦略・SWOT・財務情報
    Summer Infant, Inc. - Strategy, SWOT and Corporate Finance Report Summary Summer Infant, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pharmascience Inc-製薬・医療分野：企業M&A・提携分析
    Summary Pharmascience Inc (Pharmascience) is a pharmaceutical company that develops, manufactures and markets medicinal products. The company offers generic, prescription, over-the-counter and private label OTC products. It offers drugs in therapeutic areas of anti-inflammatory, cancer, cardiovascul …
  • Alliance Healthcare Services Inc：医療機器：M&Aディール及び事業提携情報
    Summary Alliance Healthcare Services Inc (Alliance Healthcare Services) is a provider of outsourced services including diagnostic imaging services. It provides a full line of services ranging from systems, technologists to operate the systems, sales and marketing, patient scheduling and pre-authoriz …
  • National Bank of Egypt S.A.E：企業の戦略・SWOT・財務分析
    National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report Summary National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Theranostics Health Inc-医療機器分野：企業M&A・提携分析
    Summary Theranostics Health Inc (Theranostics), a subsidiary of Avant Diagnostics Inc is a healthcare service provider that offers protein based solutions. The company provides protein based discovery and translational research services. Its products include molecular navigation of targeted therapie …
  • China Galaxy Securities Co., Ltd. (6881)：企業の財務・戦略的SWOT分析
    China Galaxy Securities Co., Ltd. (6881) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Hetero Drugs Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • B&G Foods, Inc.：企業の戦略・SWOT・財務情報
    B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cathay Life Insurance Co Ltd：企業の戦略・SWOT・財務情報
    Cathay Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Cathay Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Acerus Pharmaceuticals Corp (ASP)：製薬・医療：M&Aディール及び事業提携情報
    Summary Acerus Pharmaceuticals Corp (Acerus), formerly Trimel Pharmaceuticals Corporation develops, manufactures, markets and distributes novel innovative branded products. It focuses on providing men’s and women’s health. The company uses its proprietary drug delivery technology platforms, which in …
  • CTD Holdings Inc (CTDH)：企業の財務・戦略的SWOT分析
    Summary CTD Holdings Inc (CTDH), formerly Cyclodextrin Technologies Development Inc is a biotechnology company that develops, manufactures and distributes cyclodextrins products. The company’s products include aquaplex, trappsol and trappsol cyclo. It provides trappsol cyclo, which is a hydroxypropy …
  • Acorn Energy, Inc. (ACFN)：企業の財務・戦略的SWOT分析
    Acorn Energy, Inc. (ACFN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Banco Bradesco SA：企業の戦略・SWOT・財務情報
    Banco Bradesco SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bradesco SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Onex Corporation：企業の戦略・SWOT・財務分析
    Onex Corporation - Strategy, SWOT and Corporate Finance Report Summary Onex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Alnylam Pharmaceuticals Inc (ALNY)-製薬・医療分野：企業M&A・提携分析
    Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiova …
  • Advantagene Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Advantagene Inc (Advantagene) is a biopharmaceutical company. It manufactures, develops, and tests cancer immunotherapy drugs and gene-based biologics. It offers a proprietary Gene Mediated Cytotoxic Immunotherapy (GMCI), a platform technology designed to stimulate a patient’s immune system …
  • Genzyme Corp：製薬・医療：M&Aディール及び事業提携情報
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosi …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆